MedTrace Logo

Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children

NCT04542629 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2020-09-09

No results posted yet for this study

Summary

1. Comparison of the efficacy of Rituximab and ketogenic diet in controlling refractory seizures versus the traditional lines as corticosteroid and trace elements.
2. Improving the management of children with refractory seizures

Conditions

  • Refractory Epilepsy

Interventions

DRUG

RiTUXimab Injection [Rituxan]

375 MG/M2 /WEEK INFUSION

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Emad eldeen Mahmoud Hammad, professor · aAssiut University Children Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-08-20
Completion
2022-08-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542629 on ClinicalTrials.gov